ABC | Volume 113, Nº3, Setembro 2019

Atualização Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(3):449-663 during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147-97. 805. Martins LC, Freire CMV, Capuruçu CAB, Nunes MCP, Rezende CAL. Risk prediction of cardiovascular complications in pregnant womenwith heart disease. Arq Bras Cardiol. 2016;106(4):289-96. 806. McGregor AJ, Barron R, Rosene-Montella K. The pregnant heart: cardiac emergencies during pregnancy. Am J Emerg Med. 2015;33(4):573-9. 807. AvilaWS, Rossi EG, Ramires JA, Grinberg M, BortolottoMR, ZugaibM, et al. Pregnancy in patients with heart disease: experience with 1,000 cases. Clin Cardiol. 2003;26(3):135-42. 808. Campanharo FF, Cecatti JG, Haddad SM, Parpinelli MA, Born D, Costa ML, et al; Brazilian Network for Surveillance of Severe Maternal Morbidity Study Group. The Impact of CardiacDiseases during Pregnancy on Severe Maternal Morbidity and Mortality in Brazil. PLoS One. 2015;10(12):e0144385. 809. Tarasoutchi F, MonteraMW, GrinbergM, BarbosaMR, PiñeiroDJ, Sánchez CR, et al, sociedade Brasileira de Cardiologia. Diretriz Brasileira de Valvopatias -2011 / I Diretriz Interamericana de Valvopatias - SIAC 2011. Arq Bras Cardiol. 2011;97(5 Suppl. 1): 1-67. 810. Tedoldi CL, Freire CMV, Bub TF,et al.Sociedade Brasileira de Cardiologia. Diretriz da Sociedade Brasileira de Cardiologia para gravidez na mulher portadora de cardiopatia. Arq Bras Cardiol.2009;93(6 Suppl 1):e110-78. 811. Sliwa K, Johnson MR, Zilla P, Roos-Hesselink JW. Management of valvular disease in pregnancy: a global perspective. Eur Heart J. 2015;36(18):1078-89. 812. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. .2014;129(23):2440-92. 813. Basu S, Aggarwal P, Kakani N, Kumar A. Low-dosematernal warfarin intake resulting in fetal warfarin syndrome: In search for a safe anticoagulant regimen during pregnancy. Birth Defects Res A Clin Mol Teratol. 2016;106(2):142-7. 814. Friedrich E, Hameed AB. Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy. J Perinatol. 2010;30(4):253-7. 815. vanHagen IM, Roos-Hesselink JW, Ruys TP, MerzWM, Goland S, Gabriel H,et al; ROPAC Investigators and the EURObservationalResearch Programme (EORP) Team. Pregnancy inWomenWith aMechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015;132(2):132-42. 816. Montorsi P, De Bernardi F, Muratori M, Cavoretto D, Pepi M. Role of cine- fluoroscopy, transthoracic, and transesophageal echocardiography in patients with suspected prosthetic heart valve thrombosis. Am J Cardiol. 2000;85(1):58-64. 817. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçik M, et al. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator. Circulation. 2013;128(5):532-40. 818. Campuzano K, Roqué H, Bolnick A, Leo MV, Campbell WA. Bacterial endocarditis complicating pregnancy: case report and systematic review of the literature. Arch Gynecol Obstet. 2003;268(4):251-5. 819. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ. et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis inAdults:Diagnosis,AntimicrobialTherapy,andManagement of Complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-86. 820. HabibG,LancellottiP,AntunesMJ,BongiorniMG,CasaltaJP,DelZottiF,etal; DocumentReviewers.2015ESCGuidelinesforthemanagementofinfective endocarditis:TheTaskForcefortheManagementofInfectiveEndocarditisof theEuropeanSocietyofCardiology(ESC).Endorsedby:EuropeanAssociation for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. 821. Ruys TP, Roos-Hesselink JW, Hall R, Subirana-DomènechMT, Grando-Ting J, EstensenM, et al. Heart failure in pregnant womenwith cardiac disease: data from the ROPAC. Heart. 2014;100(3):231-8. 822. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al; Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767-78. 823. De Cara JM, Lang RM, Foley MR. Management of heart failure during pregnancy (Internet). UpToDate. 2018 Dec 5(Cited in 2016 Jun 01) Available from: https://www.uptodate.com/contents/management-of- heart-failure-during-pregnancy#H20. 824. Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J. 2015;36(18):1090-7 825. Bocchi EA, Marcondes-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues D, et al., Sociedade Brasileira de Cardiologia. Atualização da Diretriz Brasileira de Insuficiência Cardíaca Crônica - 2012. Arq Bras Cardiol 2012;98(1 Suppl 1): 1-33. 826. Haghikia A, Podewski E, Berliner D, Sonnenschein K, Fischer D, Angermann CE, et al. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function inwomenwith peripartumcardiomyopathy. Clin Res Cardiol. 2015;104(11):911-7. 827. Melo MA, Carvalho JS, Feitosa FE, Araujo Júnior E, Peixoto AB, Costa Carvalho FH, Carvalho RC. Peripartum cardiomyopathy treatment with dopamine agonist and subsequent pregnancywith a satisfactory outcome. Rev Bras Ginecol Obstet. 2016;38(6):308-13. 828. Bauersachs J, ArrigoM, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo- Leiro MG, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096-105. 829. Avila WS, de Carvalho ME, Tschaen CK, Rossi EG, Grinberg M, Mady C, et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol. 2002;79(5):484-93. 830. Dennis AT, Solnordal CB. Acute pulmonary oedema in pregnant women. Anaesthesia. 2012;67(6):646-59. 831. Sciscione AC, Ivester T, Largoza M, Manley J, Shlossman P, Colmorgen GH. Acute pulmonary edema in pregnancy. Obstet Gynecol. 2003;101(3):511-5. 832. Knotts RJ, Garan H. Cardiac arrhythmias in pregnancy. Semin Perinatol. 2014;38(5):285-8. 833. Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7(5):961-7. 834. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, et al. 2015 ACC/AHA/ HRSGuidelinefortheManagementofAdultPatientsWithSupraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J AmColl Cardiol. 2016;67(13):e27-115. 835. Driver K, Chisholm CA, Darby AE, Malhotra R, Dimarco JP, Ferguson JD. Catheter Ablation of Arrhythmia During Pregnancy. J Cardiovasc Electrophysiol. 2015;26(6):698-702. 648